Algeta, Avipep in thorium-conjugate cancer deal

Algeta ASA (OSE:ALGETA) and Avipep Pty. Ltd. (Parkville, Australia) partnered to develop a targeted thorium conjugate (TTC) combining Algeta's thorium-227, an alpha-particle emitting radionuclide, with an undisclosed Avibody from Avipep for solid tumors. Both partners will contribute financially to the one-year deal, which may be extended. Avibodies combine recombinant antibody fragments with two, three or four target binding regions. Algeta was down NOK8.50 to NOK220.60 on Tuesday. ...